HIGHER Corporation Recognized as 'Baby Unicorn' for Global Expansion of Innovative Medical Devices

HIGHER Corporation, a pioneering medical device startup, has recently been honored as a 'Baby Unicorn' by the Ministry of SMEs and Startups, alongside receiving the 'First Penguin' designation from the Korea Credit Guarantee Fund. These accolades not only validate the company's innovative approach and technological advancements but also spotlight its potential to emerge as a global unicorn in the competitive medical device sector.

The 'Baby Unicorn' program is instrumental in identifying and fostering startups with high growth potential, offering them the necessary support to scale globally. HIGHER Corporation's inclusion in this prestigious list is a testament to its groundbreaking HILO WAVE® technology, a next-generation bio-stimulator that enhances skin elasticity and hydration by stimulating natural collagen and elastin production. This innovation sets the company apart in the aesthetic medical device market, promising safer and more effective solutions for skin rejuvenation.

With a robust global business strategy, HIGHER Corporation has already made significant inroads into Southeast Asian markets, securing substantial supply contracts and laying the groundwork for expansion into Europe, Brazil, and China. The company's efforts to obtain CE MDR certification further underscore its commitment to meeting international standards and competing on a global scale.

The support from the Ministry of SMEs and Startups, including financial incentives and market development funds, will undoubtedly accelerate HIGHER Corporation's growth trajectory. This recognition not only benefits the company but also contributes to the broader economic and technological advancement of the region, reinforcing South Korea's position as a hub for innovation and entrepreneurship.

HIGHER Corporation's journey from a startup to a recognized 'Baby Unicorn' exemplifies the transformative potential of combining innovative technology with strategic global expansion. As the company continues to break new ground in the aesthetic medical device industry, its progress will be closely watched by investors, competitors, and consumers alike, eager to see how it reshapes the future of skin care and rejuvenation.